SSPC, Taighde Éireann – Research Ireland Centre for Pharmaceuticals

SSPC, an Ionad Taighde Éireann do Chógaisíocht

 

SSPC is a world-leading hub of Irish research expertise developing innovative technologies to address key challenges facing the pharmaceutical and biopharmaceutical industry. Our in-depth scientific and engineering research expertise aids companies who need tailored solutions to their bespoke challenges.

Discover Our Impacts - Faigh amach faoinár dtionchair

SSPC provides the life sciences sector with a nationally distributed, research performing community that enables high impact, collaborative research between industry and academic partners.

SSPC is committed to translating its excellent science into impact through five societal goals: Sustainability, Small Molecule, Biologics, Health, Education and Public Engagement.

Sustainability

Small Molecule

Biologics

Health

Education & Public Engagement

Talent

SSPC nurtures a talent pipeline of high calibre scientists and engineers for the sector, through our internal PhD training programme and various CPD mechanisms available to our industry partners. SSPC offers a unique proposition through its industry placement programme and 63% of SSPC graduates go on to be employed in industry both nationally and globally.

Industry

Since its inception, SSPC has successfully collaborated with over 50 industry partners, composed of indigenous and foreign operations, whose size range from small to multi-national. Collectively, this demonstrates a strong track-record in delivering applied research that enables industry to solve challenges leading to the development of better medicine. SSPC has supported 54 industry projects since 2019.

Researchers

Economic Impact since 2013

Industry Partners

Jobs created in industry following FDI

Peer-Reviewed Publications

International Co-Authors in 48 countries across 6 continents

%

Transition of Researchers to Industry

Education & Public Engagement Activities

Latest News

SSPC Industry Impact of the Year: Ayse Kont

SSPC Industry Impact of the Year: Ayse Kont

Ayse Kont, worked on a collaborative project between Boston Scientific Cork, SSPC and the School of Pharmacy, University College Cork, from April to December 2024. This successful collaboration resulted in a fellowship application for the RD&I Industry fellowship...

read more
SSPC Equality, Diversity & Inclusion Award

SSPC Equality, Diversity & Inclusion Award

Congratulations to Mary Flood, University College Dublin, Wiktoria Brytan, University of Limerick, Francesca Adami, University College Dublin, and Almudena Moreno Borrallo, Trinity College Dublin, on winning the award on behalf of the Equality, Diversity and Inclusion...

read more
SSPC EPE Champion Ayat Elgammal

SSPC EPE Champion Ayat Elgammal

Congratulations to Dr Ayat Elgammal, University College Cork, SSPC’s Education and Public Engagement champion, who is committed to making pharmaceutical research accessible by promoting knowledge exchange, trust and inclusivity that benefits both society and the...

read more

SSPC Years in Review, and News Updates

View or download our latest news and research outputs.

SSPC’s world-leading Research Programme

Our unique and innovative culture of collaboration is helping the global pharmaceutical and biopharmaceutical industry to develop more environmentally sustainable methods for drug manufacturing; to increase the range of medicines available to the public and to reduce drug manufacturing costs. SSPC’s advanced research programme extends from Molecule, Materials and Medicine into the Manufacturing and Modelling space.

These themes focus on developing new methodologies for the asymmetric synthesis of APIs, molecules & methods for automated & in-flow generation of targeted drug hybrids & new therapeutic agents.

Advancing the understanding of single-component crystalline materials (SCCMs) and, especially, multi-component crystalline materials (MCCMs) in order to enable improved orally delivered drug products.

Optimising the development, production & use of safe, effective medicines with focus on poorly soluble drugs, personalized, age appropriate medicines & rational formulation approaches with predictive performance.

Enabling a disruptive change in manufacture of drug substances & drug products, through the development & implementation of continuous manufacturing, flow chemistry & end-to-end manufacturing methodologies.

This theme will develop new techniques to design and predict behaviour in silico in order to reduce trial-and-error experimentation. Developing new transformative physical models for broad uptake in drug manufacture.